86 related articles for article (PubMed ID: 38490958)
21. Quantitative Proteomics Identifies Proteins Enriched in Large and Small Extracellular Vesicles.
Lischnig A; Bergqvist M; Ochiya T; Lässer C
Mol Cell Proteomics; 2022 Sep; 21(9):100273. PubMed ID: 35918030
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy.
Wei M; Bai X; Dong Q
Transl Cancer Res; 2022 Jun; 11(6):1630-1643. PubMed ID: 35836518
[TBL] [Abstract][Full Text] [Related]
23. Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.
Rakina M; Kazakova A; Villert A; Kolomiets L; Larionova I
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682890
[TBL] [Abstract][Full Text] [Related]
24. Influences of age, race, and sex on extracellular vesicle characteristics.
Noren Hooten N; Byappanahalli AM; Vannoy M; Omoniyi V; Evans MK
Theranostics; 2022; 12(9):4459-4476. PubMed ID: 35673574
[TBL] [Abstract][Full Text] [Related]
25. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.
Ritch SJ; Telleria CM
Front Endocrinol (Lausanne); 2022; 13():886533. PubMed ID: 35574025
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer.
Wang W; Jo H; Park S; Kim H; Kim SI; Han Y; Lee J; Seol A; Kim J; Lee M; Lee C; Dhanasekaran DN; Ahn T; Song YS
Cancer Lett; 2022 Aug; 542():215735. PubMed ID: 35569696
[TBL] [Abstract][Full Text] [Related]
27. Blood Nanoparticles - Influence on Extracellular Vesicle Isolation and Characterization.
Holcar M; Kandušer M; Lenassi M
Front Pharmacol; 2021; 12():773844. PubMed ID: 34867406
[TBL] [Abstract][Full Text] [Related]
28. The reactome pathway knowledgebase 2022.
Gillespie M; Jassal B; Stephan R; Milacic M; Rothfels K; Senff-Ribeiro A; Griss J; Sevilla C; Matthews L; Gong C; Deng C; Varusai T; Ragueneau E; Haider Y; May B; Shamovsky V; Weiser J; Brunson T; Sanati N; Beckman L; Shao X; Fabregat A; Sidiropoulos K; Murillo J; Viteri G; Cook J; Shorser S; Bader G; Demir E; Sander C; Haw R; Wu G; Stein L; Hermjakob H; D'Eustachio P
Nucleic Acids Res; 2022 Jan; 50(D1):D687-D692. PubMed ID: 34788843
[TBL] [Abstract][Full Text] [Related]
29. Framework for rapid comparison of extracellular vesicle isolation methods.
Ter-Ovanesyan D; Norman M; Lazarovits R; Trieu W; Lee JH; Church GM; Walt DR
Elife; 2021 Nov; 10():. PubMed ID: 34783650
[TBL] [Abstract][Full Text] [Related]
30. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences.
Perez-Riverol Y; Bai J; Bandla C; García-Seisdedos D; Hewapathirana S; Kamatchinathan S; Kundu DJ; Prakash A; Frericks-Zipper A; Eisenacher M; Walzer M; Wang S; Brazma A; Vizcaíno JA
Nucleic Acids Res; 2022 Jan; 50(D1):D543-D552. PubMed ID: 34723319
[TBL] [Abstract][Full Text] [Related]
31. Human Serum Extracellular Vesicle Proteomic Profile Depends on the Enrichment Method Employed.
Azkargorta M; Iloro I; Escobes I; Cabrera D; Falcon-Perez JM; Elortza F; Royo F
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681804
[TBL] [Abstract][Full Text] [Related]
32. Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix.
Bortot B; Apollonio M; Rampazzo E; Valle F; Brucale M; Ridolfi A; Ura B; Addobbati R; Di Lorenzo G; Romano F; Buonomo F; Ripepi C; Ricci G; Biffi S
Mol Oncol; 2021 Dec; 15(12):3596-3614. PubMed ID: 34614287
[TBL] [Abstract][Full Text] [Related]
33. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response.
Rickard BP; Conrad C; Sorrin AJ; Ruhi MK; Reader JC; Huang SA; Franco W; Scarcelli G; Polacheck WJ; Roque DM; Del Carmen MG; Huang HC; Demirci U; Rizvi I
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503128
[TBL] [Abstract][Full Text] [Related]
34. Robust sequential biophysical fractionation of blood plasma to study variations in the biomolecular landscape of systemically circulating extracellular vesicles across clinical conditions.
Vergauwen G; Tulkens J; Pinheiro C; Avila Cobos F; Dedeyne S; De Scheerder MA; Vandekerckhove L; Impens F; Miinalainen I; Braems G; Gevaert K; Mestdagh P; Vandesompele J; Denys H; De Wever O; Hendrix A
J Extracell Vesicles; 2021 Aug; 10(10):e12122. PubMed ID: 34429857
[TBL] [Abstract][Full Text] [Related]
35. Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin.
Veerman RE; Teeuwen L; Czarnewski P; Güclüler Akpinar G; Sandberg A; Cao X; Pernemalm M; Orre LM; Gabrielsson S; Eldh M
J Extracell Vesicles; 2021 Jul; 10(9):e12128. PubMed ID: 34322205
[TBL] [Abstract][Full Text] [Related]
36. A proximity-dependent biotinylation map of a human cell.
Go CD; Knight JDR; Rajasekharan A; Rathod B; Hesketh GG; Abe KT; Youn JY; Samavarchi-Tehrani P; Zhang H; Zhu LY; Popiel E; Lambert JP; Coyaud É; Cheung SWT; Rajendran D; Wong CJ; Antonicka H; Pelletier L; Palazzo AF; Shoubridge EA; Raught B; Gingras AC
Nature; 2021 Jul; 595(7865):120-124. PubMed ID: 34079125
[TBL] [Abstract][Full Text] [Related]
37. Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells.
Mitra A; Yoshida-Court K; Solley TN; Mikkelson M; Yeung CLA; Nick A; Lu K; Klopp AH
Sci Rep; 2021 Apr; 11(1):9149. PubMed ID: 33911091
[TBL] [Abstract][Full Text] [Related]
38. Exosomes in ovarian cancer ascites promote epithelial-mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p.
Cai J; Gong L; Li G; Guo J; Yi X; Wang Z
Cell Death Dis; 2021 Feb; 12(2):210. PubMed ID: 33627627
[TBL] [Abstract][Full Text] [Related]
39. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
40. DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model.
Wilson AL; Moffitt LR; Wilson KL; Bilandzic M; Wright MD; Gorrell MD; Oehler MK; Plebanski M; Stephens AN
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
